Anidulafungin for candidemia/invasive candidiasis in non-neutropenic ICU patients

被引：0
|
作者：
M Ruhnke
J Paiva
W Meersseman
J Pachl
I Grigoras
G Sganga
F Menichetti
P Montravers
G Auzinger
G Dimopoulos
M Borges Sá
P Miller
T Marček
M Kantecki
机构：
[1] Charité University Hospital,
[2] Hospital São João,undefined
[3] University Hospital Leuven,undefined
[4] University Hospital Královské Vinohrady,undefined
[5] University Hospital Sf Spiridon,undefined
[6] University Hospital A Gemelli,undefined
[7] University Hospital Pisa,undefined
[8] Hospital Bichat Claude Bernard,undefined
[9] King's College Hospital,undefined
[10] University Hospital Attikon,undefined
[11] Hospital Son Llatzer,undefined
[12] Pfizer,undefined
[13] Pfizer,undefined
来源：
Critical Care | / 15卷 / Suppl 1期
关键词：
Candidiasis; Azole; Global Response; Anidulafungin; Sofa Score;
D O I：
10.1186/cc9660
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Untargeted Antifungal Treatment Strategies for Invasive Candidiasis in Non-neutropenic Critically Ill Patients: Current Evidence and Insights
    Cortegiani A.
    Russotto V.
    Raineri S.M.
    Gregoretti C.
    De Rosa F.G.
    Giarratano A.
    Current Fungal Infection Reports, 2017, 11 (3) : 84 - 91
  • [42] From risk factors to biomarkers and new techniques to diagnose invasive candidiasis in non-neutropenic critically ill patients
    Ruiz-Santana, S.
    Ostrosky-Zeichner, L.
    MYCOSES, 2013, 56 : 18 - 18
  • [43] Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review
    Matteo Bassetti
    Maddalena Peghin
    Antonio Vena
    Infectious Diseases and Therapy, 2018, 7 : 17 - 27
  • [44] Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review
    Bassetti, Matteo
    Peghin, Maddalena
    Vena, Antonio
    INFECTIOUS DISEASES AND THERAPY, 2018, 7 (01) : 17 - 27
  • [45] Economic analysis of fluconazole versus amphotericin B for the treatment of candidemia in non-neutropenic patients
    Dranitsaris, G
    Phillips, P
    Rotstein, C
    Puodziunas, A
    Shafran, S
    Garber, G
    Smaill, F
    Salit, I
    Miller, M
    Williams, K
    Conly, J
    Singer, J
    Ioannou, S
    PHARMACOECONOMICS, 1998, 13 (05) : 509 - 518
  • [46] The clinical outcomes and predictive factors for in-hospital mortality in non-neutropenic patients with candidemia
    Wang, Tsai-Yu
    Hung, Chia-Yen
    Shie, Shian-Sen
    Chou, Pai-Chien
    Kuo, Chih-Hsi
    Chung, Fu-Tsai
    Lo, Yu-Lun
    Lin, Shu-Min
    MEDICINE, 2016, 95 (23)
  • [47] Economic Analysis of Fluconazole versus Amphotericin B for the Treatment of Candidemia in Non-Neutropenic Patients
    George Dranitsaris
    Peter Phillips
    Coleman Rotstein
    Anitasha Puodziunas
    Steve Shafran
    Gary Garber
    Fiona Smaill
    Irving Salit
    Mark Miller
    Kurt Williams
    John Conly
    Joel Singer
    Steve Ioannou
    PharmacoEconomics, 1998, 13 : 509 - 518
  • [48] Efficacy of caspofungin in neutropenic and non-neutropenic patients
    Glasmacher, A
    Comely, O
    Orlopp, K
    Egerer, G
    Blaschke, S
    Siemann, M
    Reuter, S
    Florek, M
    Kathofer, S
    Schnitzler, R
    Reinel, H
    Just-Nuebling, G
    BONE MARROW TRANSPLANTATION, 2003, 31 : S33 - S34
  • [49] Antifungal treatments of candidemia in non-neutropenic patients: Evaluation of practice in intensive care units
    Massanet, P.
    Corne, P.
    Conseil, M.
    Perrigault, P. -F.
    Lachaud, L.
    Jaber, S.
    Calvet, B.
    Jonquet, O.
    Reynes, J.
    MEDECINE ET MALADIES INFECTIEUSES, 2010, 40 (11): : 644 - 649
  • [50] Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients
    Trof, R. J.
    Beishuizen, A.
    Debets-Ossenkopp, Y. J.
    Girbes, A. R. J.
    Groeneveld, A. B. J.
    INTENSIVE CARE MEDICINE, 2007, 33 (10) : 1694 - 1703
12345